Intra-lineage Plasticity and Functional Reprogramming Maintain Natural Killer Cell Repertoire Diversity.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
19 Nov 2019
Historique:
received: 20 02 2019
revised: 28 08 2019
accepted: 14 10 2019
entrez: 21 11 2019
pubmed: 21 11 2019
medline: 22 9 2020
Statut: ppublish

Résumé

Natural killer (NK) cell repertoires are made up of phenotypically distinct subsets with different functional properties. The molecular programs involved in maintaining NK cell repertoire diversity under homeostatic conditions remain elusive. Here, we show that subset-specific NK cell proliferation kinetics correlate with mTOR activation, and global repertoire diversity is maintained through a high degree of intra-lineage subset plasticity during interleukin (IL)-15-driven homeostatic proliferation in vitro. Slowly cycling sorted KIR

Identifiants

pubmed: 31747601
pii: S2211-1247(19)31372-5
doi: 10.1016/j.celrep.2019.10.058
pii:
doi:

Substances chimiques

CD56 Antigen 0
CD57 Antigens 0
IL15 protein, human 0
Interleukin-15 0
KLRC1 protein, human 0
NF-kappa B 0
NK Cell Lectin-Like Receptor Subfamily C 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2284-2294.e4

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Aline Pfefferle (A)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Benedikt Jacobs (B)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Herman Netskar (H)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Eivind Heggernes Ask (EH)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Susanne Lorenz (S)

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

Trevor Clancy (T)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Jodie P Goodridge (JP)

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Fate Therapeutics, Inc., San Diego, CA, USA.

Ebba Sohlberg (E)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Karl-Johan Malmberg (KJ)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: kalle.malmberg@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH